Laddar...
Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections
There is increasing urgency in the battle against drug-resistant bacterial pathogens, and this public health crisis has created a desperate need for novel antimicrobial agents. Recombinant human lysozyme represents one interesting candidate for treating pulmonary infections, but the wild type enzyme...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Landes Bioscience
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4049907/ https://ncbi.nlm.nih.gov/pubmed/24637705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/bioe.28335 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|